Regenerative Medical Technology (RMTG) Goodwill & Intangibles (2021 - 2026)
Regenerative Medical Technology (RMTG) posted quarterly Goodwill & Intangibles of $2.2 million for Q1 2026, up 19.46% year-over-year from $1.8 million in Q1 2025, and little changed quarter-over-quarter from $2.2 million in Q4 2025.
Regenerative Medical Technology (RMTG) Goodwill & Intangibles (2021 - 2026) Analysis & Trends
Regenerative Medical Technology's Goodwill & Intangibles history runs 6 years deep, the most recent figure standing at $2.2 million for Q1 2026.
- In Q1 2026, Goodwill & Intangibles rose 19.46% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $2.2 million (up 19.46% YoY), while the FY2025 annual figure was $2.2 million, up 17.87% from the prior year.
- Goodwill & Intangibles for Q1 2026 stood at $2.2 million, roughly flat from $2.2 million in the prior quarter.
- The five-year high for Goodwill & Intangibles was $6.3 million in Q1 2022, with the low at $1.8 million in Q3 2025.
- The 5-year median for Goodwill & Intangibles is $2.2 million (2024), against an average of $3.5 million.
- The sharpest annual moves came in 2024 and 2026: Goodwill & Intangibles tumbled 69.11% in 2024, then rose 19.46% in 2026.
- Regenerative Medical Technology's Goodwill & Intangibles stood at $6.2 million in 2022, then slumped by 68.56% to $1.9 million in 2023, then decreased by 5.04% to $1.8 million in 2024, then increased by 17.87% to $2.2 million in 2025, then changed by 0.0% to $2.2 million in 2026.
- Business Quant data shows RMTG's Goodwill & Intangibles at $2.2 million in Q1 2026, $2.2 million in Q4 2025, and $1.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Regenerative Medical Technology | 1.58 Mn | 515,228.12 | 1.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.17 Mn |
| Dec 31, 2025 | 2.17 Mn |
| Sep 30, 2025 | 1.77 Mn |
| Jun 30, 2025 | 2.17 Mn |
| Mar 31, 2025 | 1.81 Mn |
| Dec 31, 2024 | 1.84 Mn |
| Sep 30, 2024 | 2.17 Mn |
| Jun 30, 2024 | 1.89 Mn |
| Mar 31, 2024 | 1.91 Mn |
| Dec 31, 2023 | 1.94 Mn |
| Sep 30, 2023 | 1.96 Mn |
| Jun 30, 2023 | 6.11 Mn |
| Mar 31, 2023 | 6.14 Mn |
| Dec 31, 2022 | 6.16 Mn |
| Sep 30, 2022 | 6.29 Mn |
| Jun 30, 2022 | 6.21 Mn |
| Mar 31, 2022 | 6.29 Mn |
| Dec 31, 2021 | 6.29 Mn |
| Sep 30, 2021 | 6.28 Mn |